Zurich-based Xeltis has raised €10.5 million Series D funding led by LSP, Kurma Partners, VI Partners and Ysios. The medtech company has developed restorative pulmonary heart valves and funds raised…
Zurich-based Xeltis has raised €10.5 million Series D funding led by LSP, Kurma Partners, VI Partners and Ysios. The medtech company has developed restorative pulmonary heart valves and funds raised…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


